People · Operator
Named in public records as an officer, director or promoter · active 2010–2011 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| ImmunoCellular Therapeutics, Ltd. | — | Pharmaceuticals | Series A | $13.3M | $8.9M | 2010 |
C. Kirk Peacock at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside C. Kirk Peacock on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| John S. Yu | 1 | 2 |
| Irach Taraporewala | 1 | 2 |
| Robert Lehman | 1 | 2 |
| Wayne Danson | 1 | 2 |
| Frank Douglas | 1 | 2 |
| Julie Kampf | 1 | 2 |
| Manish Singh | 1 | 2 |
| Richard A. Cowell | 1 | 2 |
| Eli Goldberger | 1 | 1 |
| Jacqueline Kirk Brandwynne | 1 | 1 |
| Navdeep A. Jaikaria | 1 | 1 |
| John L. Yu | 1 | 1 |
| Robert L. Martuza | 1 | 1 |
| James Kirk Bender | 1 | 1 |
| Rahul A. Singhvi | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.